Diagnostic Biomarkers in Metabolomics

A biomarker is a characteristic that is objectively measured and evaluated as an indicator of normal biologic processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention. A biomarker reveals further information to presently existing clinical and pathological analysis. It facilitates screening and detecting the disease, monitoring the progression of the disease, and predicting the diagnosis and survival after clinical intervention. A biomarker can also be used to evaluate the process of drug development and optimally to improve the efficacy and safety of disease treatment by enabling physicians to tailor treatment for individual patients. These emerging biomarkers will be beneficial and critical in developing new and clinically reliable indicators that will have a high specificity for the diagnosis.

  • Metabolite platform for validation of biomarkers
  • Biomarkers in drug development
  • Disease related biomarkers
  • Imaging biomarkers
  • Metabolomics in biomarker discovery

Related Conference of Diagnostic Biomarkers in Metabolomics

September 08-09, 2025

23rd International Conference on Structural Biology

Frankfurt, Germany
September 29-30, 2025

21st World Congress on Structural Biology

Aix-en-Provence, France
October 13-14, 2025

17th International Conference on Tissue Science and Regenerative Medicine

Rome, Italy

Diagnostic Biomarkers in Metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in